Core Viewpoint - The company clarifies that recent media reports regarding its humanoid robot core component business entering commercial production are inaccurate and misinterpret its statements [1] Group 1: Company Operations - The company's main business remains focused on the research, development, production, and sales of automotive chassis system components [1] - There are currently no orders or generated revenue from the company's intelligent bionic joint arm products [1] Group 2: Media Misinterpretation - The media reports incorrectly stated that the intelligent bionic joint arm products have entered the mass production stage and that there are over a thousand intended orders in the biopharmaceutical experimental equipment sector [1] - The company emphasizes that the intelligent bionic joint arm products have not yet reached mass production and that significant progress is still required before this can occur [1]
冠盛股份:机器人智能仿生关节臂产品未进入量产阶段